Presence of active myocarditis at the 6 month follow-up appointment for a severe form of COVID-19: a case report.

Autor: Meyer M; Geriatric Department, University Hospitals of Strasbourg, Strasbourg, 67000, France., Vogel T; Geriatric Department, University Hospitals of Strasbourg, Strasbourg, 67000, France., Meyer A; Center of Nephrology, Klinikum Offenburg, Offenburg, Germany., Constancias F; Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland., Porter LF; Department of Medical Genetics, CARGO, University Hospitals of Strasbourg, Strasbourg, France., Kaltenbach G; Geriatric Department, University Hospitals of Strasbourg, Strasbourg, 67000, France., Schmitt E; Geriatric Department, University Hospitals of Strasbourg, Strasbourg, 67000, France., Chayer S; Department of Clinical Research and Innovations, University Hospitals of Strasbourg, Strasbourg, France., Zeyons F; Department of Cardiology, University Hospitals of Strasbourg, Strasbourg, France., Riou M; Department of Pneumology, University Hospitals of Strasbourg, Strasbourg, France., Fafi-Kremer S; INSERM, UMR_S1109, LabEx TRANSPLANTEX, Research Center for Immunology and Hematology, Faculty of Medicine, University Hospital Federation (FHU) OMICARE, Federation of Translational Medicine of Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.; Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Velay A; INSERM, UMR_S1109, LabEx TRANSPLANTEX, Research Center for Immunology and Hematology, Faculty of Medicine, University Hospital Federation (FHU) OMICARE, Federation of Translational Medicine of Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.; Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., El Ghannudi S; Department of Radiology, University Hospitals of Strasbourg, Strasbourg, France.; Department of Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.
Jazyk: angličtina
Zdroj: ESC heart failure [ESC Heart Fail] 2021 Oct; Vol. 8 (5), pp. 4307-4312. Date of Electronic Publication: 2021 Jul 30.
DOI: 10.1002/ehf2.13461
Abstrakt: Here, we present the case of an 81-year-old male patient, who was hospitalized for a severe form of COVID-19. Transthoracic echocardiogram (TTE) performed 1 month after symptom onset was normal. Respiratory evolution was favourable, and the patient was discharged at Day 78. At 6 months, despite a good functional recovery, he presented pulmonary sequelae, and the TTE revealed a clear reduction of left ventricular ejection fraction (LVEF) and mild LV dilatation without cardiac symptoms. The cardiac magnetic resonance (CMR) using Lake Louise Criteria (LLC), T1 and T2 mapping showed focal infero-basal LV wall oedema, elevated T1 and T2 myocardial relaxation times especially in basal inferior and infero-lateral LV walls, and sub-epicardial late gadolinium enhancement in those LV walls. The diagnosis of active myocarditis was raised especially based on TTE abnormalities and CMR LLC, T1 and T2 mapping. Currently, we are not aware of published reports of a 6 month post-COVID-19 active myocarditis.
(© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.)
Databáze: MEDLINE
Externí odkaz: